SFRP4 and triple-A syndrome: The enhanced expression of ECM-related genes (i.e., Col1a1 and Timp1) and WNT antagonists (i.e. Sfrp2 and Sfrp4) in fibrocytes (Figure 4F) suggests a protective effect in AAA formation.